On July 11, 2012, Merus Labs International Inc. acquired Emselex®/Enablex®. Stewart Muglich and Victor Dudas of our Corporate Finance & Securities Group handled the debt facility between Merus and PDL BioPharma Inc., a company that supports the healthcare industry with creative financing solutions, assisted by Amaan Gangji and Kevin MacDonald. The transaction involved counsel from Toronto, New York, Switzerland, the Netherlands and Luxembourg.
Related Content
Timing of an occurrence matters
R.C. Heating & Gasfitting Ltd. v. The Sovereign General Insurance Company, 2017 BCSC 1916 Most liability policies may be classified as either occurrence or claims-made ... Continued
OSC Considers Omission of Gender Diversity Disclosure Serious Infraction
The OSC has taken fairly severe action against TSX listed companies that have failed to provide gender diversity information as required by amendments to National ... Continued
2010 Annual Review of Law and Practice
The 19th edition of the CLE-BC Annual Review of Law & Practice has been released, with contributions by Clark Wilson lawyers. Allyson Baker, Glen Boswall, ... Continued